cours de bourse
14/08/2009 - 11:07:23|49.66 EUR 0.42 %
ORALAIR® (Sweet Vernal, Orchard, Perennial Rye, Timothy and Kentucky Blue...
New positive clinical results from a phase III study, published in...
STALLERGENES, a global allergy player
Stallergenes is a global pharmaceutical company with leading innovation, provider of allergy solutions all around the world. Stallergenes has a comprehensive approach of the allergic diseases with a complete portfolio combining diagnosis products and treatments and has brought the new generation of allergen immunotherapy treatments.
Approval of Oralair® in the USA